TITLE

Transmission of Streptococcus pneumoniaein Rural Gambian Villages: A Longitudinal Study

AUTHOR(S)
Hill, Philip C.; Townend, John; Antonio, Martin; Akisanya, Biodun; Ebruke, Chinelo; Lahai, George; Greenwood, Brian M.; Adegbola, Richard A.
PUB. DATE
June 2010
SOURCE
Clinical Infectious Diseases;6/1/2010, Vol. 50 Issue 11, p1468
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background. To prepare for national introduction of a pneumococcal vaccine of restricted valency, we studied the pattern of nasopharyngeal carriage of Streptococcus pneumoniae and its transmission in Gambian villages over time. Methods. We collected nasopharyngeal swab specimens every 2 weeks from 158 villagers in 19 households in 2 villages over 1 year. We studied the prevalence and duration of S. pneumoniae carriage, the effect of household size and composition on carriage, and sequence type-specific carriage within and between households. Results. Ninety-seven percent of children and 85% of adults carried S. pneumoniae at some time. Fifty-three serotypes were represented among 1522 isolates. Carriage was more common among children than adults for all serotypes studied except 9V. There was an overall trend toward shorter carriage with increasing age (Pp.043) and significant differences in carriage duration between serotypes. For most serotypes, the odds of being a carrier were greater if there were other carriers in the household. The prevalence of carriage varied by serotype. Most notably, serotype 5 carriage occurred in only 1 village and was transient. Multilocus sequence typing of serotype 6B isolates from 1 village revealed 8 different sequence types and strong evidence of nonrandom distribution among households (P!.001). Study by sequence type suggested household spread starting most commonly in children, followed by spread to adults. Conclusions. This longitudinal carriage study in Gambian villages provides unique information on the pattern of spread of S. pneumoniae in rural Africa and a baseline for evaluating the impact of the introduction of pneumococcal conjugate vaccine into the region.
ACCESSION #
50936138

 

Related Articles

  • Increased Penicillin Nonsusceptibility of Nonvaccine-Serotype Invasive Pneumococci Other than Serotypes 19A and 6A in Post-7-Valent Conjugate Vaccine Era. Gertz Jr., Robert E.; Zhongya Li; Pimenta, Fabiana C.; Jackson, Delois; Juni, Billie A.; Lynfield, Ruth; Jorgensen, James H.; da Gloria Carvalho, Maria; Beall, Bernard W. // Journal of Infectious Diseases;3/1/2010, Vol. 201 Issue 5, p770 

    According to population-based invasive pneumococcal surveillance in the United States during 2007, 898 (26%) of 3,511 isolates were penicillin nonsusceptible. Non-7-valent pneumococcal conjugate vaccine (PCV7) serotypes other than 19A accounted for 40% of these penicillin-nonsusceptible...

  • Pneumococcal Immunization: From Policy to Practice. Schwartz, Benjamin; Breiman, Robert F. // JAMA: Journal of the American Medical Association;9/5/90, Vol. 264 Issue 9, p1154 

    Editorial. Deals with the low utilization of pneumococcal vaccines targeted for adults in the U.S. Factors behind the lack of use of pneumococcal vaccines; Strategies that can be adopted to increase utilization of pneumococcal vaccines; Cost benefits of immunization.

  • General considerations.  // WHO Technical Report Series;2004, Issue 927, p66 

    The article focuses on polysaccharide vaccines for infections caused by Streptococcus pneumoniae, which are responsible for substantial morbidity and mortality, commonly on children and the elderly. Pneumociccus are classified based on chemical and serological distinct capsular polysaccharides....

  • New children's vaccines, new direction. Kassianos, George // GP: General Practitioner;1/12/2007, p30 

    The article focuses on issues related to the introduction of routine immunization of infants against pneumococcal disease in Great Britain. The new immunization schedule was announced on June 12, 2006. One of the problems of introducing a new vaccine is how to fit another vaccine into the...

  • Prevenar joins schedule in June. Reid, Stewart // New Zealand Doctor;5/7/2008, p17 

    The article focuses on the use of Prevenar as vaccine. According to the author, starting June 1, 2008 heptavalent conjugate pneumococcal vaccine Prevenar will be part of the New Zealand routine immunization schedule. The immunization will have a four-dose schedule with doses at six weeks, three,...

  • The Prevalence and Risk Factors for Pneumococcal Colonization of the Nasopharynx among Children in Kilifi District, Kenya. Abdullahi, Osman; Karani, Angela; Tigoi, Caroline C.; Mugo, Daisy; Kungu, Stella; Wanjiru, Eva; Jomo, Jane; Musyimi, Robert; Lipsitch, Marc; Scott, J. Anthony G. // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    Background: Pneumococcal conjugate vaccines (PCV) reduce nasopharyngeal carriage of vaccine-serotype pneumococci but increase in the carriage of non-vaccine serotypes. We studied the epidemiology of carriage among children 3-59 months old before vaccine introduction in Kilifi, Kenya. Methods: In...

  • The Prevalence and Risk Factors for Pneumococcal Colonization of the Nasopharynx among Children in Kilifi District, Kenya. Abdullahi, Osman; Karani, Angela; Tigoi, Caroline C.; Mugo, Daisy; Kungu, Stella; Wanjiru, Eva; Jomo, Jane; Musyimi, Robert; Lipsitch, Marc; Scott, J. Anthony G. // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    Background: Pneumococcal conjugate vaccines (PCV) reduce nasopharyngeal carriage of vaccine-serotype pneumococci but increase in the carriage of non-vaccine serotypes. We studied the epidemiology of carriage among children 3-59 months old before vaccine introduction in Kilifi, Kenya. Methods: In...

  • Vaccination against pneumococcus in West Africa: perspectives and prospects. Donkor, Eric S.; Dayie, Nicholas T. K. D.; Badoe, Ebenezer V. // International Journal of General Medicine;2013, Vol. 6, p757 

    Background: Pneumococcal vaccination has become obligatory due to the enormous burden of pneumococcal diseases. Quite recently, pneumococcal conjugate vaccines have been developed, and have been shown to be superior to the previous polyvalent polysaccharide vaccine of the organism. Pneumococcal...

  • Changing Epidemiology of Invasive Pneumococcal Disease in Canada, 1998-2007: Update from the Calgary-Area Streptococcus pneumoniae Research (CASPER) Study. Kellner, James D.; Vanderkooi, Otto G.; MacDonald, Judy; Church, Deirdre L.; Tyrrell, Gregory J.; Scheifele, David W. // Clinical Infectious Diseases;7/15/2009, Vol. 49 Issue 2, p205 

    Background. Routine infant vaccination with 7-valent pneumococcal conjugate vaccine (PCV7) began in the Calgary Health Region (Alberta, Canada) in 2002. We measured the impact of this vaccine program on invasive pneumococcal disease (IPD). Methods. Prospective, population-based surveillance of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics